BTK and B-cell non-Hodgkin lymphoma: Bruton tyrosine kinase (BTK), a member of the Tec tyrosine kinases family, plays a central role in B cell lymphomas, and BTK inhibitors are increasingly replacing chemotherapy-based regimens, particularly in patients with chronic lymphocytic leukemia and MCL.